U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 205234

Expand all

TELMISARTAN AND AMLODIPINE (AMLODIPINE BESYLATE; TELMISARTAN)
EQ 5MG BASE;40MG
Marketing Status: Discontinued
Active Ingredient: AMLODIPINE BESYLATE; TELMISARTAN
Proprietary Name: TELMISARTAN AND AMLODIPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE;40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A205234
Product Number: 001
Approval Date: Nov 17, 2016
Applicant Holder Full Name: ALEMBIC PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information
TELMISARTAN AND AMLODIPINE (AMLODIPINE BESYLATE; TELMISARTAN)
EQ 5MG BASE;80MG
Marketing Status: Discontinued
Active Ingredient: AMLODIPINE BESYLATE; TELMISARTAN
Proprietary Name: TELMISARTAN AND AMLODIPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE;80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A205234
Product Number: 003
Approval Date: Nov 17, 2016
Applicant Holder Full Name: ALEMBIC PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information
TELMISARTAN AND AMLODIPINE (AMLODIPINE BESYLATE; TELMISARTAN)
EQ 10MG BASE;40MG
Marketing Status: Discontinued
Active Ingredient: AMLODIPINE BESYLATE; TELMISARTAN
Proprietary Name: TELMISARTAN AND AMLODIPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE;40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A205234
Product Number: 002
Approval Date: Nov 17, 2016
Applicant Holder Full Name: ALEMBIC PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information
TELMISARTAN AND AMLODIPINE (AMLODIPINE BESYLATE; TELMISARTAN)
EQ 10MG BASE;80MG
Marketing Status: Discontinued
Active Ingredient: AMLODIPINE BESYLATE; TELMISARTAN
Proprietary Name: TELMISARTAN AND AMLODIPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE;80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A205234
Product Number: 004
Approval Date: Nov 17, 2016
Applicant Holder Full Name: ALEMBIC PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top